Friday, May 7, 2021

Tag: Intracellular Sigma Peptide (ISP)

Injectable Peptide Might Help Spinal Cord Injury Patients Walk Again

A systemically injectable peptide, which may make it possible to restore lost functions in spinal cord injury patients, is moving toward clinical trials in early 2020. The treatment, which was developed by Jerry Silver, a...

Dr Jerry Silver – Spinal Cord Damage and Emerging Treatments

Injuries to the spinal cord can cause permanent paralysis and even lead to death, with little to no hope of regaining lost functions once the trauma has occurred. Dr Jerry Silver and his team at...

Controlling Immune Response in Spinal Cord Injury Patients

The immune system of spinal cord injury patients can be controlled using a family of therapeutic stem cells, according to findings published in Scientific Reports. Researchers from Case Western Reserve University studied the therapeutic stem...

Scientists break early barrier to treating spinal cord injuries

http://youtu.be/FK_7gEk6n2c NIH-funded scientists developed a promising new drug that may lead to spinal cord injury treatments. Video courtesy of the NINDS and Silver lab, Case Western Reserve School of Medicine. Read more here: https://www.spinalcordinjuryzone.com/?p=13775
Intracellular Sigma Peptide

Peptide Shows Great Promise for Treating Spinal Cord Injury

Case Western Reserve Scientists Design Intracellular Sigma Peptide (ISP) to Promote Functional Recovery Following Spinal Cord Injury Case Western Reserve scientists have developed a new chemical compound that shows extraordinary promise in restoring function lost...